July 14, 2026
How Research Sites Find and Win Studies
How clinical trial sites actually find studies and get selected: sponsor and CRO relationships, feasibility, site networks, and why sponsors are short on sites.
This is the part that decides whether a research site thrives or sits idle. You can do everything right, get fully qualified, and still enroll nobody, because being ready and being chosen are two different things. Finding studies and winning them is the real job of running a site, and almost nobody teaches it. Here's how it actually works.
The uncomfortable truth
Most studies get handed out through relationships. Sponsors and CROs go back to sites they already know and trust, because a known site is a safer bet than a stranger. A brand-new independent practice isn't on that list, so it can be perfectly capable and simply never get asked. That's not a reflection on your medicine. It's how the system is wired, and it's why business development, not regulatory paperwork, is what separates busy sites from idle ones.
Where studies come from
- Sponsor and CRO relationships. The main channel, and it runs on repeat business.
- ClinicalTrials.gov and trial databases, where you can find recruiting studies and trace the sponsor behind them.
- Site networks and SMOs, which bring studies to their member sites.
- Feasibility outreach, where you respond to questionnaires for studies you'd fit.
Why sponsors are actually short on sites
Here's the twist that works in your favor. Sponsors need new sites far more than it feels like from the outside. Around 80% of trials run late or collapse because of recruitment. A large share of sites under-enroll, and some enroll nobody at all. On top of that, investigator turnover is high, with a big chunk of PIs running one study and never doing another. So sponsors are constantly hunting for fresh, capable sites. They're just bad at finding them. The demand is real, the matchmaking is broken, and that broken matchmaking is your opening.
How new sites break in
- Get findable. A strong, sponsor-ready site profile and a clear therapeutic focus so the right sponsors can tell you fit.
- Go outbound. Don't sit and wait to be discovered. Identify studies recruiting for your patients and reach out to the sponsors and CROs directly.
- Deliver on your first study. Enroll well and you land on the "sites we know" list. That's the flywheel, and it's how one study turns into a pipeline.
- Consider a network or a tool that handles the business development so you don't have to build it from scratch.
Where TrialWave fits
This is the exact gap TrialWave is built to close. It finds the studies that fit your patients, scores them for fit, and runs the outreach to the sponsors and CROs behind them, so you get in front of the people handing out studies instead of waiting to be noticed. It's the business-development engine an independent site doesn't otherwise have. It doesn't run the trial or give medical or regulatory advice. It gets you in the room.
The bottom line
Finding studies isn't luck, and it isn't only about who you already know. It's a repeatable process: know your patients, present a strong site, go outbound, deliver, repeat. The sites that treat business development as a real job are the ones that stay busy. If you're just getting set up, start with how to become a clinical trial site.
Want to see what's recruiting patients like yours right now? Start a free TrialWave trial, no card required.
This is general information, not medical, legal, or regulatory advice. Site selection practices vary by sponsor and CRO.